Impact of Neoadjuvant and Adjuvant Pleural Intensity‐Modulated Radiotherapy in Multimodality Treatment for Malignant Pleural Mesothelioma
Neoadjuvant pleural IMRT has been investigated as a novel treatment option for highly selected cases in pleural mesothelioma. Neoadjuvant IMRT was effective and safe in patients treated in a high-volume institution but showed no relevant survival benefit compared to adjuvant IMRT within multimodality treatment.
Authors
- Daniela Gompelmann (ORCID: https://orcid.org/0000-0002-4857-9854)
- Ariane Steindl (ORCID: https://orcid.org/0000-0002-5839-8301)
- Mir Alireza Hoda (ORCID: https://orcid.org/0000-0002-7088-8768)
- Joachim Widder (ORCID: https://orcid.org/0000-0002-9972-6690)
- Martin Heilmann (ORCID: https://orcid.org/0009-0006-0759-5053)
- Štefan Schwarz (ORCID: https://orcid.org/0000-0002-6303-8212)
- Karin Dieckmann (ORCID: https://orcid.org/0000-0002-5311-2976)
- Thomas Klikovits (ORCID: https://orcid.org/0000-0003-1012-0404)
- Sabine Zöchbauer‐Müller (ORCID: https://orcid.org/0000-0002-6777-1729)
- Katharina Sinn (ORCID: https://orcid.org/0000-0002-3936-2354)
- Berta Mosleh (ORCID: https://orcid.org/0009-0005-9805-9733)
- Clemens Aigner (ORCID: https://orcid.org/0000-0002-7787-991X)
- Anna Cho (ORCID: https://orcid.org/0000-0002-5211-382X)
- Wolfgang J. Köstler
Institutions
- Comprehensive Cancer Center Vienna (AT)
- Medical University of Vienna (AT)
Publication Details
- Journal
- Thoracic Cancer
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1111/1759-7714.70024
- Citations
- 2
- Primary Topic
- Occupational and environmental lung diseases
- Type
- article
- Field-Weighted Citation Impact
- 3.04